Rhythm Pharmaceuticals, Inc. (BMV:RYTM)

Rhythm Pharmaceuticals Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 17, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	108,945	128,605	71,688	45,928	32,007	10,285
Market Cap Growth	49.95%	79.39%	56.09%	43.49%	211.21%	-60.67%
Enterprise Value	106,436	125,795	70,779	40,893	25,264	3,608
Last Close Price	1866.76	1866.76	958.00	553.07	550.00	185.04
PS Ratio	31.89	37.65	26.44	35.09	69.42	159.06
PB Ratio	22.41	26.46	20.91	16.00	6.21	1.77
P/TBV Ratio	45.24	53.41	221.17	16.69	6.40	1.80
EV/Sales Ratio	32.60	36.82	26.10	31.24	54.79	55.81
Debt / Equity Ratio	0.42	0.42	0.69	0.63	0.29	0.01
Net Debt / Equity Ratio	-1.02	-1.02	-1.26	-0.99	-0.97	-1.03
Net Debt / EBITDA Ratio	1.45	1.45	1.21	0.92	1.44	1.73
Net Debt / FCF Ratio	2.37	2.37	1.82	1.24	1.47	2.00
Asset Turnover	0.44	0.44	0.36	0.22	0.07	0.01
Inventory Turnover	0.88	0.88	0.98	1.61	1.41	-
Quick Ratio	3.92	3.92	2.94	5.27	8.53	6.81
Current Ratio	4.41	4.41	3.24	5.58	8.90	7.10
Return on Equity (ROE)	-90.45%	-90.45%	-155.91%	-85.10%	-66.05%	-30.89%
Return on Assets (ROA)	-27.51%	-27.51%	-29.84%	-32.22%	-31.45%	-41.15%
Return on Capital Employed (ROCE)	-51.30%	-51.30%	-62.50%	-66.40%	-52.30%	-59.40%
Earnings Yield	-3.34%	-2.75%	-7.58%	-6.80%	-11.04%	-13.88%
FCF Yield	-1.93%	-1.63%	-3.31%	-5.01%	-10.59%	-29.19%
Buyback Yield / Dilution	-6.54%	-6.54%	-5.76%	-10.65%	-5.08%	-12.40%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.